The potential role of borophene as a radiosensitizer in boron neutron capture therapy (BNCT) and particle therapy (PT)

Laser-Synthesized Elemental Boron Nanoparticles for Efficient Boron Neutron Capture Therapy

Boron neutron capture therapy (BNCT) is one of the most appealing radiotherapy modalities, whose localization can be further improved by the employment of boron-containing nanoformulations, but the fabrication of biologically friendly, water-dispersible nanoparticles (NPs) with high boron content and favorable physicochemical characteristics still presents a great challenge. Here, we explore the use of elemental boron (B) NPs (BNPs) fabricated using the methods of pulsed laser ablation in liquids as sensitizers of BNCT. Depending on the conditions of laser-ablative synthesis, the used NPs were amorphous (a-BNPs) or partially crystallized (pc-BNPs) with a mean size of 20 nm or 50 nm, respectively. Both types of BNPs were functionalized with polyethylene glycol polymer to improve colloidal stability and biocompatibility. The NPs did not initiate any toxicity effects up to concentrations of 500 µg/mL, based on the results of MTT and clonogenic assay tests. The cells with BNPs incubated at a 10B concentration of 40 µg/mL were then irradiated with a thermal neutron beam for 30 min. We found that the presence of BNPs led to a radical enhancement in cancer cell death, namely a drop in colony forming capacity of SW-620 cells down to 12.6% and 1.6% for a-BNPs and pc-BNPs, respectively, while the relevant colony-forming capacity for U87 cells dropped down to 17%. The effect of cell irradiation by neutron beam uniquely was negligible under these conditions. Finally, to estimate the dose and regimes of irradiation for future BNCT in vivo tests, we studied the biodistribution of boron under intratumoral administration of BNPs in immunodeficient SCID mice and recorded excellent retention of boron in tumors. The obtained data unambiguously evidenced the effect of a neutron therapy enhancement, which can be attributed to efficient BNP-mediated generation of α-particles.

Facile Synthesis of Oxidized Boron Nanosheets for Chemo- and Biosensing

As recently emerging nanomaterials, boron nanosheets (BNSs) have attracted more and more attention in various fields such as supercapacitors, photodetectors, bioimaging, and electrocatalysis due to their advantages of good biological compatibility, environmental friendliness, and good electro-optical properties. However, the study and application of BNSs in chemical and biological sensing are still in the infant stage, mainly due to the requirement of complicated, high-cost, and time-consuming preparation strategies. In this work, a new class of BNSs, namely oxidized-BNSs (i.e., ox-BNSs), were easily and rapidly synthesized by chemically treating boron powder with diluted HNO₃ in a very short time (less than 15 min). The composition, morphology, optical property, and peroxidase mimetic activity of obtained ox-BNSs were investigated in detail. The prepared ox-BNSs were several-layered nanosheets with abundant oxygen-containing groups, emitted blue fluorescence, and possessed good intrinsic peroxidase mimetic activity, based on which a sensitive and selective colorimetric sensor was developed for detection of H₂O₂ and glucose. The new easy preparation strategy and good sensing performances of the prepared ox-BNSs would greatly stimulate the study and application of BNSs in chemo- and biosensing.

Exploring the Potential Applications of Engineered Borophene in Nanobiosensing and Theranostics

A monolayer of boron known as borophene has emerged as a novel and fascinating two-dimensional (2D) material with exceptional features, such as anisotropic metallic behavior and supple mechanical and optical capabilities. The engineering of smart functionalized opto-electric 2D materials is essential to obtain biosensors or biodevices of desired performance. Borophene is one of the most emerging 2D materials, and owing to its excellent electroactive surface area, high electron transport, anisotropic behavior, controllable optical and electrochemical properties, ability to be deposited on thin films, and potential to create surface functionalities, it has recently become one of the sophisticated platforms. Despite the difficulty of production, borophene may be immobilized utilizing chemistries, be functionalized on a flexible substrate, and be controlled over electro-optical properties to create a highly sensitive biosensor system that could be used for point-of-care diagnostics. Its electrochemical properties can be tailored by using appropriate nanomaterials, redox mediators, conducting polymers, etc., which will be quite useful for the detection of biomolecules at even trace levels with a high sensitivity and less detection time. This will be quite helpful in developing biosensing devices with a very high sensitivity and with less response time. So, this review will be a crucial foundation as we have discussed the basic properties, synthesis, and potential applications of borophene in nanobiosensing, as well as therapeutic applications.

Ag+-doped boron quantum dots with enhanced stability and fluorescence enabling versatile practicality in visual detection, sensing, imaging and photocatalytic degradation

In this work, a metal-doping strategy was put forward to construct metal-doped borophene and the corresponding zero-dimensional boron. Through theoretical calculations, Ag⁺ acts as the optimal metal ions to prepare Ag⁺-doped borophene derived boron quantum dots (Ag-BQDs). As predicted theoretically, doping of Ag⁺ endows borophene with enhanced stability of electronic structures. The newly emerging Ag-BQDs were experimentally acquired from ultrasonic-assisted liquid-phase exfoliation of bulk boron and solvothermal treatments. According to theoretical and experimental studies, the improved stability and fluorescence (FL) of Ag-BQDs are due to the formation of strong B-Ag bonding to competitively suppress B-O bonding. The function enables the maximal protection of borophene electronic structures from oxidization, destruction and reconfiguration. Because of Ag-BQDs with relatively higher colloidal and FL stability over BQDs, potential applications of Ag-BQDs were further explored in promising fields toward FL visualization in aqueous solutions and on filter paper, employed as a chemosensor of Fe³⁺ for FL sensing and visual detection at the solid/liquid phases, utilized for multiple FL bio-imaging at the levels of fresh plants, live animals and live cells of fresh plants, and applied to photocatalytic degradation of organic dyes and anticancer drug. Experimental results demonstrate excellent performances of Ag-BQDs in multiple applications, including versatile FL sensing and visual detection, unique multi-channel FL bio-imaging and visible-light-driven photodegradation of organic pollutants, toxic and harmful substances. This work can promote the development of metal-ion-doped low- dimensional nanomaterials with improved stability and FL properties for significant applications.

Metal-Doped Boron Quantum Dots for Versatile Detection of Lactate and Fluorescence Bioimaging

To improve the stability and fluorescence (FL) of monoelemental boron nanomaterials, this work put forward a metal-coordination strategy to explore emerging metal-doped boron quantum dots, Co@BQDs. Through theoretical calculations, B-Co bonding as predicted can suppress the B-O reaction and protect the electronic structures of exfoliated two-dimensional (2D) boron from oxidation and decomposition upon exposure to oxygen. In experimental studies, Co²⁺ was added into a dispersion liquid of bulk boron and subjected to probe sonication to promote Co²⁺ adsorption on the surface of exfoliated 2D boron, followed by Co²⁺ coordination with exposed boron atoms. Solvothermal treatment of exfoliated 2D boron resulted in the generation of Co²⁺-doped 0D boron Co@BQDs. Experimental results confirm that Co@BQDs have higher colloidal and FL stability than BQDs as a reference. B-Co bonding formation to suppress the B-O reaction ensures the high stability of exfoliated boron structures. A dispersion liquid of Co@BQDs with stable and bright FL was used for visual FL imaging of solutions and solid substrates. Based on enzymatic and cascade oxidation-induced FL quenching of Co@BQDs, a novel FL bio-probe of lactate was explored. This bio-probe, with a broad detection range of 0.01-10 mM and a low detection limit of 3.1 μM, enables FL sensing of lactate in biosamples and shows high detection recoveries of 98.0-102.8%. Moreover, this bio-probe realized versatile FL imaging and visual detection of lactate in liquid/solid-phase systems. These results demonstrate great prospects of Co@BQDs as emerging and efficient imaging reagents for long-term tracking and bioimaging applications.

Clinical Viability of Boron Neutron Capture Therapy for Personalized Radiation Treatment

Simple Summary

Usually, for dose planning in radiotherapy, the tumor is delimited as a volume on the image of the patient together with other clinical considerations based on populational evidence. However, the same prescription dose can provide different results, depending on the patient. Unfortunately, the biological aspects of the tumor are hardly considered in dose planning. Boron Neutron Capture Radiotherapy enables targeted treatment by incorporating boron-10 at the cellular level and irradiating with neutrons of a certain energy so that they produce nuclear reactions locally and almost exclusively damage the tumor cell. This technique is not new, but modern neutron generators and more efficient boron carriers have reactivated the clinical interest of this technique in the pursuit of more precise treatments. In this work, we review the latest technological facilities and future possibilities for the clinical implementation of BNCT and for turning it into a personalized therapy.

Abstract

Boron Neutron Capture Therapy (BNCT) is a promising binary disease-targeted therapy, as neutrons preferentially kill cells labeled with boron (¹⁰B), which makes it a precision medicine treatment modality that provides a therapeutic effect exclusively on patient-specific tumor spread. Contrary to what is usual in radiotherapy, BNCT proposes cell-tailored treatment planning rather than to the tumor mass. The success of BNCT depends mainly on the sufficient spatial biodistribution of ¹⁰B located around or within neoplastic cells to produce a high-dose gradient between the tumor and healthy tissue. However, it is not yet possible to precisely determine the concentration of ¹⁰B in a specific tissue in real-time using non-invasive methods. Critical issues remain to be resolved if BNCT is to become a valuable, minimally invasive, and efficient treatment. In addition, functional imaging technologies, such as PET, can be applied to determine biological information that can be used for the combined-modality radiotherapy protocol for each specific patient. Regardless, not only imaging methods but also proteomics and gene expression methods will facilitate BNCT becoming a modality of personalized medicine. This work provides an overview of the fundamental principles, recent advances, and future directions of BNCT as cell-targeted cancer therapy for personalized radiation treatment.

Monoelemental two-dimensional boron nanomaterials beyond theoretical simulations: From experimental preparation, functionalized modification to practical applications

During the past decade, there is an explosive growth of theoretical and computational studies on 2D boron-based nanomaterials. In terms of extensive predictions from theoretical simulations, borophene, boron nanosheets and 2D boron derivatives show excellent structural, electronic, photonic and nonlinear optical characteristics, and potential applications in a wide range of fields. In recent years, previous studies have reported the successful experimental preparations, superior properties, multi-functionalized modifications of various 2D boron and its derivatives, which show many practical applications in significant fields. To further promote the ever-increasing experimental studies, this present review systematically summarizes recent progress on experimental preparation methods, functionalized modification strategies and practical applications of 2D boron-based nanomaterials and multifunctional derivatives. Firstly, this review summarizes the experimental preparation methods, including molecular beam epitaxy, chemical vapor deposition, liquid-phase exfoliation, chemical reaction, and other auxiliary methods. Then, various strategies for functionalized modification are introduced overall, focusing on borophene derivatives, boron-based nanosheets, atom-introduced, chemically-functionalized borophene and boron nanosheets, borophene or boron nanosheet-based heterostructures, and other functionalized 2D boron nanomaterials. Subsequently, various potential applications are discussed in detail, involving energy storage, catalysis conversion, photonics, optoelectronics, sensors, bio-imaging, biomedicine therapy, and adsorption. We comment the state-of-the-art related studies concisely, and also discuss the current status, probable challenges and perspectives rationally. This review is timely, comprehensive, in-depth and highly attractive for scientists from multiple disciplines and scientific fields, and can facilitate further development of advanced functional low-dimensional nanomaterials and multi-functionalized systems toward high-performance practical applications in significant fields.

Importance of radiobiological studies for the advancement of boron neutron capture therapy (BNCT)

Boron neutron capture therapy (BNCT) is a tumour selective particle radiotherapy, based on the administration of boron carriers incorporated preferentially by tumour cells, followed by irradiation with a thermal or epithermal neutron beam. BNCT clinical results to date show therapeutic efficacy, associated with an improvement in patient quality of life and prolonged survival. Translational research in adequate experimental models is necessary to optimise BNCT for different pathologies. This review recapitulates some examples of BNCT radiobiological studies for different pathologies and clinical scenarios, strategies to optimise boron targeting, enhance BNCT therapeutic effect and minimise radiotoxicity. It also describes the radiobiological mechanisms induced by BNCT, and the importance of the detection of biomarkers to monitor and predict the therapeutic efficacy and toxicity of BNCT alone or combined with other strategies. Besides, there is a brief comment on the introduction of accelerator-based neutron sources in BNCT. These sources would expand the clinical BNCT services to more patients, and would help to make BNCT a standard treatment modality for various types of cancer. Radiobiological BNCT studies have been of utmost importance to make progress in BNCT, being essential to design novel, safe and effective clinical BNCT protocols.

Polymer-Stabilized Elemental Boron Nanoparticles for Boron Neutron Capture Therapy: Initial Irradiation Experiments

Sufficient boron-10 isotope (10B) accumulation by tumor cells is one of the main requirements for successful boron neutron capture therapy (BNCT). The inability of the clinically registered 10B-containing borophenylalanine (BPA) to maintain a high boron tumor concentration during neutron irradiation after a single injection has been partially solved by its continuous infusion; however, its lack of persistence has driven the development of new compounds that overcome the imperfections of BPA. We propose using elemental boron nanoparticles (eBNPs) synthesized by cascade ultrasonic dispersion and destruction of elemental boron microparticles and stabilized with hydroxyethylcellulose (HEC) as a core component of a novel boron drug for BNCT. These HEC particles are stable in aqueous media and show no apparent influence on U251, U87, and T98G human glioma cell proliferation without neutron beam irradiation. In BNCT experiments, cells incubated with eBNPs or BPA at an equivalent concentration of 40 µg 10B/mL for 24 h or control cells without boron were irradiated at an accelerator-based neutron source with a total fluence of thermal and epithermal neutrons of 2.685, 5.370, or 8.055 × 1012/cm2. The eBNPs significantly reduced colony-forming capacity in all studied cells during BNCT compared to BPA, verified by cell-survival curves fit to the linear-quadratic model and calculated radiobiological parameters, though the effect of both compounds differed depending on the cell line. The results of our study warrant further tumor targeting-oriented modifications of synthesized nanoparticles and subsequent in vivo BNCT experiments.

Borophene as an emerging 2D flatland for biomedical applications: current challenges and future prospects

Recently, two-dimensional (2D)-borophene has emerged as a remarkable translational nanomaterial substituting its predecessors in the field of biomedical sensors, diagnostic tools, high-performance healthcare devices, super-capacitors, and energy storage devices. Borophene justifies its demand due to high-performance and controlled optical, electrical, mechanical, thermal, and magnetic properties as compared with other 2D-nanomaterials. However, continuous efforts are being made to translate theoretical and experimental knowledge into pragmatic platforms. To cover the associated knowledge gap, this review explores the computational and experimental chemistry needed to optimize borophene with desired properties. High electrical conductivity due to destabilization of the highest occupied molecular orbital (HOMO), nano-engineering at the monolayer level, chemistry-oriented biocompatibility, and photo-induced features project borophene for biosensing, bioimaging, cancer treatment, and theragnostic applications. Besides, the polymorphs of borophene have been useful to develop specific bonding for DNA sequencing and high-performance medical equipment. In this review, an overall critical and careful discussion of systematic advancements in borophene-based futuristic biomedical applications including artificial intelligence (AI), Internet-of-Things (IoT), and Internet-of-Medical Things (IoMT) assisted smart devices in healthcare to develop high-performance biomedical systems along with challenges and prospects is extensively addressed. Consequently, this review will serve as a key supportive platform as it explores borophene for next-generation biomedical applications. Finally, we have proposed the potential use of borophene in healthcare management strategies.

Two-dimensional biomaterials: material science, biological effect and biomedical engineering applications

To date, nanotechnology has increasingly been identified as a promising and efficient means to address a number of challenges associated with public health. In the past decade, two-dimensional (2D) biomaterials, as a unique nanoplatform with planar topology, have attracted explosive interest in various fields such as biomedicine due to their unique morphology, physicochemical properties and biological effect. Motivated by the progress of graphene in biomedicine, dozens of types of ultrathin 2D biomaterials have found versatile bio-applications, including biosensing, biomedical imaging, delivery of therapeutic agents, cancer theranostics, tissue engineering, as well as others. The effective utilization of 2D biomaterials stems from the in-depth knowledge of structure-property-bioactivity-biosafety-application-performance relationships. A comprehensive summary of 2D biomaterials for biomedicine is still lacking. In this comprehensive review, we aim to concentrate on the state-of-the-art 2D biomaterials with a particular focus on their versatile biomedical applications. In particular, we discuss the design, fabrication and functionalization of 2D biomaterials used for diverse biomedical applications based on the up-to-date progress. Furthermore, the interactions between 2D biomaterials and biological systems on the spatial-temporal scale are highlighted, which will deepen the understanding of the underlying action mechanism of 2D biomaterials aiding their design with improved functionalities. Finally, taking the bench-to-bedside as a focus, we conclude this review by proposing the current crucial issues/challenges and presenting the future development directions to advance the clinical translation of these emerging 2D biomaterials.

Boron neutron capture therapy: Current status and future perspectives

The development of new accelerators has given a new impetus to the development of new drugs and treatment technologies using boron neutron capture therapy (BNCT). We analyzed the current status and future directions of BNCT for cancer treatment, as well as the main issues related to its introduction. This review highlights the principles of BNCT and the key milestones in its development: new boron delivery drugs and different types of charged particle accelerators are described; several important aspects of BNCT implementation are discussed. BCNT could be used alone or in combination with chemotherapy and radiotherapy, and it is evaluated in light of the outlined issues. For the speedy implementation of BCNT in medical practice, it is necessary to develop more selective boron delivery agents and to generate an epithermal neutron beam with definite characteristics. Pharmacological companies and research laboratories should have access to accelerators for large-scale screening of new, more specific boron delivery agents.